Alice B Gottlieb
Overview
Explore the profile of Alice B Gottlieb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
354
Citations
8065
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Childs B, Romanelli S, Merola J, Gottlieb A
J Clin Aesthet Dermatol
. 2025 Mar;
18(2):16-22.
PMID: 40078858
Psoriasis (PsO) is an immune-mediated, chronic inflammatory skin disease that significantly impairs quality of life. Its treatment landscape is rapidly evolving, providing better disease control. Here, we highlight updates in...
2.
Gordon K, Augustin M, Barker J, Tada Y, Lebwohl M, Tang M, et al.
J Am Acad Dermatol
. 2025 Mar;
PMID: 40057892
Background: Generalized pustular psoriasis (GPP) is a chronic inflammatory disease with an unpredictable disease course. Long-term treatment goals include sustained resolution of skin symptoms, prevention of new flares, and improvement...
3.
Armstrong A, Lee K, Yee D, Woodbury M, Zundell M, Zagona-Prizio C, et al.
JAMA Dermatol
. 2025 Feb;
PMID: 40009402
Importance: A critical need exists for developing a validated dermatologic-specific treatment satisfaction instrument. Objective: To evaluate the structural validity, internal consistency, construct validity, and test-retest reliability of the 7-item dermatology-specific...
4.
Merola J, Zhang A, Childs B, Li M, Smith J, Chong B, et al.
J Invest Dermatol
. 2025 Feb;
PMID: 39924049
No abstract available.
5.
Gladman D, Mease P, Gossec L, Husni M, Gottlieb A, Ink B, et al.
J Rheumatol
. 2025 Feb;
PMID: 39892885
Objective: To assess the longer-term effect of bimekizumab up to 1 year on patient-reported symptoms, health-related quality of life (HRQOL), and work productivity in patients with active PsA who were...
6.
Perez-Chada L, Gondo G, Grant C, Woodbury M, Kucharik A, Armstrong A, et al.
J Invest Dermatol
. 2025 Jan;
PMID: 39864735
No abstract available.
7.
Lebwohl M, Deodhar A, Schwartzman S, Salvarani C, Feely McDonald M, Bello N, et al.
Dermatol Ther (Heidelb)
. 2025 Jan;
15(1):161-188.
PMID: 39843709
Introduction: Psoriasis (PsO), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) may confer an increased risk for cardiovascular (CV) disease, including major adverse cerebro-cardiovascular events (MACE), deep vein thrombosis (DVT), and...
8.
Burshtein J, Armstrong A, Chow M, DeBusk L, Glick B, Gottlieb A, et al.
J Am Acad Dermatol
. 2024 Dec;
PMID: 39709077
Background: Psoriasis is a chronic inflammatory skin disease often associated with obesity. Psoriasis therapies may be less effective in patients with obese. The purpose of this expert consensus panel is...
9.
Zhang A, Ball G, Zundell M, Aguero R, Yee D, Shields A, et al.
J Drugs Dermatol
. 2024 Dec;
23(12):1114-1120.
PMID: 39630678
Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization whose mission is to improve the availability of evidence-based, consensus-driven outcome measures for dermatological diseases. IDEOM facilitates collaboration between stakeholders...
10.
Harris J, Pandya A, Lebwohl M, Hamzavi I, Grimes P, Gottlieb A, et al.
Skin Health Dis
. 2024 Dec;
4(6):e404.
PMID: 39624731
No abstract available.